Science Overview

This report presents an overview of the latest scientific consensus understanding of the effect of aviation emissions on the atmosphere for both local air quality and climate change in order to provide a contextual framework for raising future questions to help assess the environmental benefits of technology goals. The questions may take the form of what are the environmental benefits that would result if goals are achieved, what are the consequences for other aviation pollutants, and whether tools exist to evaluate the trade-off. In addition to this documents, presentations will be made at the meeting to illustrate current developing views on these subjects. To facilitate studies on trade-offs among environmental impacts from aviation, one must start with scientific investigations that quantify the impacts. A second step is to select representative metrics with policy relevance so that diverse impacts can be put on the same common scale. The IPCC Special Report on Aviation (IPCC, 1999) serves as an excellent example of the first step. The report was produced by IPCC's Working Group 1, whose mandate is to provide the assessment of the scientific aspects of the climate system and climate change. An example of the second step is Witt et al. (2005), a study commissioned by the Environment DG of the European Commission. Within the context of CAEP, step 1 is aligned with the responsibilities of the Research Focal Points, while step 2 is more related to activities of FESG. These steps are likely to be iterative as proposed policy options will raise new science questions, and new science will expand or limit policy options. Past experiences show that clearly defined policy-related scientific needs will help focus the scientific community to marshal their intellects to provide the needed answers

Combination strategies for pandemic influenza response - a systematic review of mathematical modeling studies

<p>Abstract</p> <p>Background</p> <p>Individual strategies in pandemic preparedness plans may not reduce the impact of an influenza pandemic.</p> <p>Methods</p> <p>We searched modeling publications through PubMed and associated references from 1990 to 30 September 2009. Inclusion criteria were modeling papers quantifying the effectiveness of combination strategies, both pharmaceutical and non-pharmaceutical.</p> <p>Results</p> <p>Nineteen modeling papers on combination strategies were selected. Four studies examined combination strategies on a global scale, 14 on single countries, and one on a small community. Stochastic individual-based modeling was used in nine studies, stochastic meta-population modeling in five, and deterministic compartmental modeling in another five. As part of combination strategies, vaccination was explored in eight studies, antiviral prophylaxis and/or treatment in 16, area or household quarantine in eight, case isolation in six, social distancing measures in 10 and air travel restriction in six studies. Two studies suggested a high probability of successful influenza epicenter containment with combination strategies under favorable conditions. During a pandemic, combination strategies delayed spread, reduced overall number of cases, and delayed and reduced peak attack rate more than individual strategies. Combination strategies remained effective at high reproductive numbers compared with single strategy. Global cooperative strategies, including redistribution of antiviral drugs, were effective in reducing the global impact and attack rates of pandemic influenza.</p> <p>Conclusion</p> <p>Combination strategies increase the effectiveness of individual strategies. They include pharmaceutical (antiviral agents, antibiotics and vaccines) and non-pharmaceutical interventions (case isolation, quarantine, personal hygiene measures, social distancing and travel restriction). Local epidemiological and modeling studies are needed to validate efficacy and feasibility.</p

Science Overview: The LTTG Technology Review Meeting March 2006 Summary Report

This report presents an overview of the latest scientific consensus understanding of the effect of aviation emissions on the atmosphere for both local air quality and climate change in order to provide a contextual framework for raising future questions to help assess the environmental benefits of technology goals. Although studies of the two issues share a common framework (of quantifying the emissions, the change in concentrations in the atmosphere, and the environmental impacts), the communities of practitioners are distinctly different. The scientific community will continue to provide guidelines on trade-off among different contributors to a specific environmental impact, such as global climate, or local air quality. Ultimately, monetization of the costs and benefits of mitigation actions is the proper tool for quantifying and analyzing trade-offs between the two issues. Scientific assessment of the impacts and their uncertainties are critical inputs to these analyses. Until environmental effects of aviation emerge as a policy driven issue, there is little incentive within the scientific community to focus on research efforts specific to trade-off studies between local and global impacts

Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii

SummaryObjectivesTo describe the clinical features, treatments, outcomes, and subtype prevalence of cryptococcosis in Singapore.MethodsAll patients with laboratory confirmed cryptococcal infections admitted from 1999 to 2007 to a teaching hospital in Singapore were reviewed retrospectively. Identification and molecular types of Cryptococcus neoformans variants and Cryptococcus gattii were determined by polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP). Serotypes were inferred with a multiplex PCR method.ResultsOf 62 patients with cryptococcosis, C. neoformans var. grubii was the predominant subtype (in 95%), affecting mainly immunocompromised hosts (91%) with HIV infection (80%). Patients with HIV were younger (median age 36.5 vs. 49.5 years, p=0.006) and less likely to present with an altered mental status (14% vs. 50%, p=0.013). In contrast, delayed treatment (median 7 days vs. 2 days, p=0.03), pulmonary involvement (58% vs. 14%, p=0.03), and initial treatment with fluconazole (25% vs. 2%, p=0.02) were more common in HIV-negative patients. C. gattii was uncommon, affecting only three patients, all of whom were immunocompetent and had disseminated disease with pulmonary and neurological involvement. All C. gattii were RFLP type VG II, serotype B and all C. neoformans var. grubii were RFLP type VN I, serotype A, except for one that was RFLP type VN II.ConclusionC. neoformans var. grubii, subtype VN I, was the predominant subtype in Singapore, infecting younger, mainly immunocompromised hosts with HIV. C. gattii was uncommon, causing pulmonary manifestations in older, immunocompetent patients and were RFLP type VG II

Simple Clinical and Laboratory Predictors of Chikungunya versus Dengue Infections in Adults

10.1371/journal.pntd.0001786PLoS Neglected Tropical Diseases69

Chikungunya Outbreak, Singapore, 2008

10.3201/eid1505.081390Emerging Infectious Diseases155836-83

Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus

Zika virus (ZIKV), a flavivirus with homology to dengue virus (DENV), is spreading to areas of DENV hyper-endemicity. Heterologous T cell immunity, whereby virus-specific memory T cells are activated by variant peptides derived from a different virus, can lead to enhanced viral clearance or diminished protective immunity and altered immunopathology. In mice, CD8+ T cells specific for DENV provide in vivo protective efficacy against subsequent ZIKV infection. In humans, contrasting studies report complete absence or varying degrees of DENV/ZIKV T cell cross-reactivity. Moreover, the impact of cross-reactive T cell recognition on the anti-viral capacity of T cells remains unclear. Here, we show that DENV-specific memory T cells display robust cross-reactive recognition of ZIKV NS3 ex vivo and after in vitro expansion in respectively n = 7/10 and n = 9/9 dengue-immune individuals tested. In contrast, cross-reactivity toward ZIKV capsid is low or absent. Cross-reactive recognition of DENV or ZIKV NS3 peptides elicits similar production of the anti-viral effector mediators IFN-γ, TNF-α, and CD107a. We identify 9 DENV/ZIKV cross-reactive epitopes, 7 of which are CD4+ and 2 are CD8+ T cell epitopes. We also show that cross-reactive CD4+ and CD8+ T cells targeting novel NS3 epitopes display anti-viral effector potential toward ZIKV-infected cells, with CD8+ T cells mediating direct lyses of these cells. Our results demonstrate that DENV NS3-specific memory T cells display anti-viral effector capacity toward ZIKV, suggesting a potential beneficial effect in humans of pre-existing T cell immunity to DENV upon ZIKV infection

Continuous enzymatic hydrolysis of sugar beet pectin and l-arabinose recovery within an integrated biorefinery

Sugar beet pulp (SBP) fractionated by steam explosion, released sugar beet pectin (SB-pectin) which was selectively hydrolysed using a novel α-l-arabinofuranosidase (AF), yielding monomeric l-arabinose (Ara) and a galacturonic acid rich backbone (GABB). AF was immobilised on an epoxy-functionalised resin with 70% overall immobilisation yield. Pretreatment of SB-pectin, to remove coloured compounds, improved the stability of the immobilised AF, allowing its reutilisation for up to 10 reaction cycles in a stirred tank reactor. Continuous hydrolysis of SB-pectin was subsequently performed using a packed bed reactor (PBR) with immobilised AF. Reactor performance was evaluated using a Design of Experiment approach. Pretreated SB-pectin hydrolysis was run for 7 consecutive days maintaining 73% of PBR performance. Continuous separation of Ara from GABB was achieved by tangential flow ultrafiltration with 92% Ara recovery. These results demonstrate the feasibility of establishing a continuous bioprocess to obtain Ara from the inexpensive SBP biomass